Analysts Set Expectations for Teladoc Health FY2027 Earnings

Teladoc Health, Inc. (NYSE:TDOC) – Equities researchers at Zacks Research issued their FY2027 earnings per share estimates for shares of Teladoc Health in a research note issued on Wednesday, March 12th. Zacks Research analyst R. Department expects that the health services provider will earn ($0.71) per share for the year. The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million.

A number of other research firms also recently weighed in on TDOC. Piper Sandler cut their target price on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. The Goldman Sachs Group cut their target price on Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, March 3rd. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Bank of America upped their target price on Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research report on Wednesday, February 12th. Finally, Oppenheimer cut their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. Eleven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $11.26.

Teladoc Health Stock Performance

Shares of NYSE TDOC opened at $8.63 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock’s fifty day moving average price is $10.58 and its two-hundred day moving average price is $9.67. Teladoc Health has a one year low of $6.76 and a one year high of $15.68. The firm has a market cap of $1.50 billion, a price-to-earnings ratio of -1.49 and a beta of 1.27.

Hedge Funds Weigh In On Teladoc Health

Several large investors have recently bought and sold shares of the company. PKO Investment Management Joint Stock Co bought a new position in Teladoc Health in the fourth quarter valued at about $227,000. Brucke Financial Inc. bought a new position in Teladoc Health in the fourth quarter valued at about $92,000. Vise Technologies Inc. raised its position in Teladoc Health by 4.9% in the fourth quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock valued at $274,000 after purchasing an additional 1,405 shares during the last quarter. PharVision Advisers LLC bought a new position in Teladoc Health in the fourth quarter valued at about $301,000. Finally, Twinbeech Capital LP raised its position in Teladoc Health by 63.8% in the fourth quarter. Twinbeech Capital LP now owns 382,735 shares of the health services provider’s stock valued at $3,479,000 after purchasing an additional 149,118 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.